The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Calcium Channel Blockers-Global Market Insights and Sales Trends 2024
Synopsis
Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
The global Calcium Channel Blockers market size is expected to reach US$ 104 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Calcium Channel Blockers in various end use industries. The expanding demands from the Hypertension, Coronary Artery Disease, Arrhythmia and Cardiomyopathy, are propelling Calcium Channel Blockers market. Selective Blockers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Selective Blockers segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Calcium Channel Blockers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Calcium Channel Blockers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Calcium Channel Blockers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Calcium Channel Blockers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Calcium Channel Blockers covered in this report include Pfizer, Aventis, Searle, Bayer, AstraZeneca, Knoll Pharmaceuticals, Wyeth-Ayerst, AstraZeneca and Novartis, etc.
The global Calcium Channel Blockers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
Global Calcium Channel Blockers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Calcium Channel Blockers market, Segment by Type:
Selective Blockers
Non-Selective Blockers
Global Calcium Channel Blockers market, by Application
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Calcium Channel Blockers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Calcium Channel Blockers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
The global Calcium Channel Blockers market size is expected to reach US$ 104 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Calcium Channel Blockers in various end use industries. The expanding demands from the Hypertension, Coronary Artery Disease, Arrhythmia and Cardiomyopathy, are propelling Calcium Channel Blockers market. Selective Blockers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Selective Blockers segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Calcium Channel Blockers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Calcium Channel Blockers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Calcium Channel Blockers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Calcium Channel Blockers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Calcium Channel Blockers covered in this report include Pfizer, Aventis, Searle, Bayer, AstraZeneca, Knoll Pharmaceuticals, Wyeth-Ayerst, AstraZeneca and Novartis, etc.
The global Calcium Channel Blockers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
Global Calcium Channel Blockers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Calcium Channel Blockers market, Segment by Type:
Selective Blockers
Non-Selective Blockers
Global Calcium Channel Blockers market, by Application
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Calcium Channel Blockers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Calcium Channel Blockers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Calcium Channel Blockers Market Overview
1.1 Calcium Channel Blockers Product Overview
1.2 Calcium Channel Blockers Market Segment by Type
1.2.1 Selective Blockers
1.2.2 Non-Selective Blockers
1.3 Global Calcium Channel Blockers Market Size by Type
1.3.1 Global Calcium Channel Blockers Market Size Overview by Type (2018-2029)
1.3.2 Global Calcium Channel Blockers Historic Market Size Review by Type (2018-2023)
1.3.3 Global Calcium Channel Blockers Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Calcium Channel Blockers Sales Breakdown by Type (2018-2023)
1.4.2 Europe Calcium Channel Blockers Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Calcium Channel Blockers Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Calcium Channel Blockers Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Calcium Channel Blockers Sales Breakdown by Type (2018-2023)
2 Global Calcium Channel Blockers Market Competition by Company
2.1 Global Top Players by Calcium Channel Blockers Sales (2018-2023)
2.2 Global Top Players by Calcium Channel Blockers Revenue (2018-2023)
2.3 Global Top Players by Calcium Channel Blockers Price (2018-2023)
2.4 Global Top Manufacturers Calcium Channel Blockers Manufacturing Base Distribution, Sales Area, Product Type
2.5 Calcium Channel Blockers Market Competitive Situation and Trends
2.5.1 Calcium Channel Blockers Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Calcium Channel Blockers Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Calcium Channel Blockers as of 2022)
2.7 Date of Key Manufacturers Enter into Calcium Channel Blockers Market
2.8 Key Manufacturers Calcium Channel Blockers Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Calcium Channel Blockers Status and Outlook by Region
3.1 Global Calcium Channel Blockers Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Calcium Channel Blockers Historic Market Size by Region
3.2.1 Global Calcium Channel Blockers Sales in Volume by Region (2018-2023)
3.2.2 Global Calcium Channel Blockers Sales in Value by Region (2018-2023)
3.2.3 Global Calcium Channel Blockers Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Calcium Channel Blockers Forecasted Market Size by Region
3.3.1 Global Calcium Channel Blockers Sales in Volume by Region (2024-2029)
3.3.2 Global Calcium Channel Blockers Sales in Value by Region (2024-2029)
3.3.3 Global Calcium Channel Blockers Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Calcium Channel Blockers by Application
4.1 Calcium Channel Blockers Market Segment by Application
4.1.1 Hypertension
4.1.2 Coronary Artery Disease
4.1.3 Arrhythmia
4.1.4 Cardiomyopathy
4.2 Global Calcium Channel Blockers Market Size by Application
4.2.1 Global Calcium Channel Blockers Market Size Overview by Application (2018-2029)
4.2.2 Global Calcium Channel Blockers Historic Market Size Review by Application (2018-2023)
4.2.3 Global Calcium Channel Blockers Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Calcium Channel Blockers Sales Breakdown by Application (2018-2023)
4.3.2 Europe Calcium Channel Blockers Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Calcium Channel Blockers Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Calcium Channel Blockers Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Calcium Channel Blockers Sales Breakdown by Application (2018-2023)
5 North America Calcium Channel Blockers by Country
5.1 North America Calcium Channel Blockers Historic Market Size by Country
5.1.1 North America Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Calcium Channel Blockers Sales in Volume by Country (2018-2023)
5.1.3 North America Calcium Channel Blockers Sales in Value by Country (2018-2023)
5.2 North America Calcium Channel Blockers Forecasted Market Size by Country
5.2.1 North America Calcium Channel Blockers Sales in Volume by Country (2024-2029)
5.2.2 North America Calcium Channel Blockers Sales in Value by Country (2024-2029)
6 Europe Calcium Channel Blockers by Country
6.1 Europe Calcium Channel Blockers Historic Market Size by Country
6.1.1 Europe Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Calcium Channel Blockers Sales in Volume by Country (2018-2023)
6.1.3 Europe Calcium Channel Blockers Sales in Value by Country (2018-2023)
6.2 Europe Calcium Channel Blockers Forecasted Market Size by Country
6.2.1 Europe Calcium Channel Blockers Sales in Volume by Country (2024-2029)
6.2.2 Europe Calcium Channel Blockers Sales in Value by Country (2024-2029)
7 Asia-Pacific Calcium Channel Blockers by Region
7.1 Asia-Pacific Calcium Channel Blockers Historic Market Size by Region
7.1.1 Asia-Pacific Calcium Channel Blockers Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Calcium Channel Blockers Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Calcium Channel Blockers Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Calcium Channel Blockers Forecasted Market Size by Region
7.2.1 Asia-Pacific Calcium Channel Blockers Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Calcium Channel Blockers Sales in Value by Region (2024-2029)
8 Latin America Calcium Channel Blockers by Country
8.1 Latin America Calcium Channel Blockers Historic Market Size by Country
8.1.1 Latin America Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Calcium Channel Blockers Sales in Volume by Country (2018-2023)
8.1.3 Latin America Calcium Channel Blockers Sales in Value by Country (2018-2023)
8.2 Latin America Calcium Channel Blockers Forecasted Market Size by Country
8.2.1 Latin America Calcium Channel Blockers Sales in Volume by Country (2024-2029)
8.2.2 Latin America Calcium Channel Blockers Sales in Value by Country (2024-2029)
9 Middle East and Africa Calcium Channel Blockers by Country
9.1 Middle East and Africa Calcium Channel Blockers Historic Market Size by Country
9.1.1 Middle East and Africa Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Calcium Channel Blockers Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Calcium Channel Blockers Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Calcium Channel Blockers Forecasted Market Size by Country
9.2.1 Middle East and Africa Calcium Channel Blockers Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Calcium Channel Blockers Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Calcium Channel Blockers Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Calcium Channel Blockers Products Offered
10.1.5 Pfizer Recent Development
10.2 Aventis
10.2.1 Aventis Company Information
10.2.2 Aventis Introduction and Business Overview
10.2.3 Aventis Calcium Channel Blockers Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Aventis Calcium Channel Blockers Products Offered
10.2.5 Aventis Recent Development
10.3 Searle
10.3.1 Searle Company Information
10.3.2 Searle Introduction and Business Overview
10.3.3 Searle Calcium Channel Blockers Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Searle Calcium Channel Blockers Products Offered
10.3.5 Searle Recent Development
10.4 Bayer
10.4.1 Bayer Company Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Calcium Channel Blockers Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bayer Calcium Channel Blockers Products Offered
10.4.5 Bayer Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Calcium Channel Blockers Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AstraZeneca Calcium Channel Blockers Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Knoll Pharmaceuticals
10.6.1 Knoll Pharmaceuticals Company Information
10.6.2 Knoll Pharmaceuticals Introduction and Business Overview
10.6.3 Knoll Pharmaceuticals Calcium Channel Blockers Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Knoll Pharmaceuticals Calcium Channel Blockers Products Offered
10.6.5 Knoll Pharmaceuticals Recent Development
10.7 Wyeth-Ayerst
10.7.1 Wyeth-Ayerst Company Information
10.7.2 Wyeth-Ayerst Introduction and Business Overview
10.7.3 Wyeth-Ayerst Calcium Channel Blockers Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Wyeth-Ayerst Calcium Channel Blockers Products Offered
10.7.5 Wyeth-Ayerst Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information
10.8.2 AstraZeneca Introduction and Business Overview
10.8.3 AstraZeneca Calcium Channel Blockers Sales, Revenue and Gross Margin (2018-2023)
10.8.4 AstraZeneca Calcium Channel Blockers Products Offered
10.8.5 AstraZeneca Recent Development
10.9 Novartis
10.9.1 Novartis Company Information
10.9.2 Novartis Introduction and Business Overview
10.9.3 Novartis Calcium Channel Blockers Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Novartis Calcium Channel Blockers Products Offered
10.9.5 Novartis Recent Development
10.10 Sanofi
10.10.1 Sanofi Company Information
10.10.2 Sanofi Introduction and Business Overview
10.10.3 Sanofi Calcium Channel Blockers Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Sanofi Calcium Channel Blockers Products Offered
10.10.5 Sanofi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Calcium Channel Blockers Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Calcium Channel Blockers Industrial Chain Analysis
11.4 Calcium Channel Blockers Market Dynamics
11.4.1 Calcium Channel Blockers Industry Trends
11.4.2 Calcium Channel Blockers Market Drivers
11.4.3 Calcium Channel Blockers Market Challenges
11.4.4 Calcium Channel Blockers Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Calcium Channel Blockers Distributors
12.3 Calcium Channel Blockers Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
